Solexa Ships 13 Sequencers in ’06, Expects to Post First Instrument Revenues in Q1
 
Solexa said this week that it shipped 13 Genome Analysis Systems to 10 early-access customers in five countries last year and began invoicing these customers in the fourth quarter.
 
The company said it will make the system “broadly available” to customers this quarter. The firm added that it expects to begin recording revenue from placements in the current quarter.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.